Back to Journals » Drug Design, Development and Therapy

Drug Design, Development and Therapy

ISSN: 1177-8881


Editor-in-Chief: Prof. Dr. Frank Boeckler

An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal. 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

Intravenous Odatroltide for Acute Ischemic Stroke Within 24 Hours of Onset: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Chao AC, Lee TH, Pettigrew LC, Hannawi Y, Huang HY, Chi NF, Chan L, Chen PL, Devlin T

Drug Design, Development and Therapy 2024, 18:2033-2042

Published Date: 6 June 2024

Focus on Trabectedin in Ovarian Cancer: What Do We Still Need to Know?

Boccia SM, Sassu CM, Ergasti R, Vertechy L, Apostol AI, Palluzzi E, Fagotti A, Scambia G, Marchetti C

Drug Design, Development and Therapy 2024, 18:2021-2032

Published Date: 7 June 2024

Analysis of Clinical Trials Using Anti-Tumor Traditional Chinese Medicine Monomers

Lv D, Liu Y, Tang R, Fu S, Kong S, Liao Q, Li H, Lin L

Drug Design, Development and Therapy 2024, 18:1997-2020

Published Date: 5 June 2024

Unveiling the Pharmacological Mechanisms of Davidiin’s Anti-Diabetic Efficacy in Streptozotocin-Treated Rats: A Comprehensive Analysis of Serum Metabolome

Li M, Zhou X, Huang D, Zhao Y, Chen J, Dong Z, Chen W, Zhang F, Sun L

Drug Design, Development and Therapy 2024, 18:1981-1996

Published Date: 5 June 2024


Read more articles